Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio: 2018-2025
Historic Asset Utilization Ratio for Crinetics Pharmaceuticals (CRNX) over the last 4 years, with Sep 2025 value amounting to 0.00.
- Crinetics Pharmaceuticals' Asset Utilization Ratio was N/A to 0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.00, marking a year-over-year change of. This contributed to the annual value of 0.00 for FY2024, which is 87.65% down from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.00 for Q3 2025, which was down 15.15% from 0.00 recorded in Q2 2025.
- In the past 5 years, Crinetics Pharmaceuticals' Asset Utilization Ratio registered a high of 0.02 during Q2 2023, and its lowest value of 0.00 during Q1 2025.
- Moreover, its 3-year median value for Asset Utilization Ratio was 0.00 (2024), whereas its average is 0.01.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 51.70% in 2023, then plummeted by 84.42% in 2024.
- Quarterly analysis of 4 years shows Crinetics Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2022, then decreased by 0.60% to 0.01 in 2023, then tumbled by 84.42% to 0.00 in 2024, then fell by 26.05% to 0.00 in 2025.
- Its last three reported values are 0.00 in Q3 2025, 0.00 for Q2 2025, and 0.00 during Q1 2025.